Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Farmak Tafamidis

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Tafamidis

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,268Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025
    Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025

    29 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-discontinue-low-dose-attr-drug-vyndaqel-us-ahead-2028-patent-loss

    FIERCE PHARMA
    29 Aug 2025
    Share Share
    Dexcel`s Generics Tafamidis Receives Tentative Approval in US
    Dexcel`s Generics Tafamidis Receives Tentative Approval in US

    15 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218365

    FDA
    15 Oct 2024
    Share Share
    BridgeBio Shares Data On Serum TTR Increase With Acoramidis
    BridgeBio Shares Data On Serum TTR Increase With Acoramidis

    30 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/30/2938591/0/en/BridgeBio-Shares-Data-on-Serum-TTR-Increase-When-Switching-Participants-from-Placebo-and-Tafamidis-to-Acoramidis-in-ATTRibute-CM-and-its-Open-Label-Extension.html

    GLOBENEWSWIRE
    30 Aug 2024
    Share Share
    Zenara Pharma`s Generics Tafamidis Receives Tentative Approval in US
    Zenara Pharma`s Generics Tafamidis Receives Tentative Approval in US

    21 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

    FDA
    21 Aug 2024
    Share Share
    Alnylam touts 'big-win scenario' for closely watched heart trial
    Alnylam touts 'big-win scenario' for closely watched heart trial

    25 Jun 2024

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/alnylam-ceo-touts-big-win-scenario-amvuttra-closely-watched-heart-disease-trial

    Angus Liu FIERCE PHARMA
    25 Jun 2024
    Share Share
    Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM
    Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM

    13 May 2024

    // PHARMAPHORUM

    https://pharmaphorum.com/news/pfizer-reaches-deal-nice-vyndaqel-attr-cm

    PHARMAPHORUM
    13 May 2024
    Share Share